XML 57 R46.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Investments (Cost-Method Investments) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended |
--- | --- | --- | ---
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 | Dec. 31, 2016
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Cost method investments | $ 38,636 |  | $ 38,636 |  | $ 33,777
Foreign exchange and other gains (losses) | 491 | $ 1,216 | 957 | $ (2) |
ImThera Medical, Inc. | Cost Method Investee | Other Assets |  |  |  |  |
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Outstanding loans | 1,000 |  | 1,000 |  |
Cost Method Investee | Respicardia | Other Assets |  |  |  |  |
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Outstanding loans | 1,500 |  | 1,500 |  |
Respicardia |  |  |  |  |
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Cost method investments | 21,129 |  | 21,129 |  | 17,518
ImThera Medical, Inc. |  |  |  |  |
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Cost method investments | 12,000 |  | 12,000 |  | 12,000
Rainbow Medical Ltd. |  |  |  |  |
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Cost method investments | 4,178 |  | 4,178 |  | 3,733
MD Start II |  |  |  |  |
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Cost method investments | 1,179 |  | 1,179 |  | 526
Other |  |  |  |  |
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Cost method investments | $ 150 |  | 150 |  | $ 0
Istituto Europeo di Oncologia S.R.L. |  |  |  |  |
Schedule of Cost-method Investments [Line Items] |  |  |  |  |
Foreign exchange and other gains (losses) |  |  | $ 3,200 |  |

X
- Definition Foreign Currency Transaction Gain (Loss) and Other Nonoperating Income + References No definition available. + Details
Name: | livn_ForeignCurrencyTransactionGainLossandOtherNonoperatingIncome
Namespace Prefix: | livn_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Original amount of cost-method investments at the acquisition date. + References No definition available. + Details
Name: | us-gaap_CostMethodInvestmentsOriginalCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition For an unclassified balance sheet, reflects the carrying amount of unpaid loan amounts due from related parties at the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.7(e)) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864 + Details
Name: | us-gaap_LoansAndLeasesReceivableRelatedParties
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCostMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CounterpartyNameAxis=livn_ImTheraMedicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=livn_CostMethodInvesteeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=livn_CostMethodInvesteeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_CounterpartyNameAxis=livn_RespicardiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_RespicardiaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_ImTheraMedicalInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_RainbowMedicalLtd.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_MDStartIIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_OtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=livn_IstitutoEuropeodiOncologiaS.R.L.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |